Prevalence and Association of Dysfunctional Breathing With Nicotine Dependence and Physical Activity Among Young Smokers
Prevalence of Dysfunctional Breathing and Its Association With Nicotine Dependence and Physical Activity Level Among Young Smokers: A Cross-Sectional Study
We will structure the study's summary to provide a clear and accessible overview for patients, families, and healthcare providers. The research will examine young adult cigarette smokers aged 18 to 24 to estimate the prevalence of a dysfunctional breathing-compatible symptom pattern using the Nijmegen Questionnaire. Furthermore, the study will assess how nicotine dependence severity-measured via the Fagerström Test for Nicotine Dependence-and physical activity levels-assessed using the International Physical Activity Questionnaire-relate to this symptom burden. We will recruit participants through social media announcements and conduct face-to-face evaluations at Istinye University. The project will employ hierarchical linear and binary logistic regression models, adjusting for age, sex, and body mass index, to determine independent predictors of dysfunctional breathing. Ultimately, the findings will provide valuable insights into the combined impacts of smoking severity and physical activity on respiratory health in young adults.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
The study population will consist of young adult cigarette smokers aged 18 to 24 recruited through social media announcements, who will undergo face-to-face evaluation and eligibility assessments at a single center.
Descripción
Inclusion Criteria:
- Being between 18 and 24 years of age.
- Reporting current cigarette smoking (daily or occasionally) at the time of assessment
Exclusion Criteria:
- Having a diagnosed personality disorder.
- Having a substance use disorder.
- Engaging in regular meditation or breathing exercises.
- Having a chronic cardiovascular or pulmonary disease.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: OTHER
- Perspectivas temporales: CROSS_SECTIONAL
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Young adult cigarette smokers.
|
This study will not involve any experimental medical treatment or intervention. It will be an observational evaluation where participants will complete self-report instruments, including the Fagerström Test for Nicotine Dependence, the International Physical Activity Questionnaire, and the Nijmegen Questionnaire, along with a sociodemographic form during a single face-to-face session. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Fagerström Test for Nicotine Dependence
Periodo de tiempo: Measured once during the single face-to-face evaluation session
|
his instrument will assess the severity of nicotine dependence through six items evaluating daily cigarette consumption and smoking patterns. |
Measured once during the single face-to-face evaluation session
|
|
Nijmegen Questionnaire
Periodo de tiempo: Measured once during the single face-to-face evaluation session.
|
This questionnaire will assess the symptom burden of respiratory, neurovegetative, and neuromuscular features to identify a dysfunctional breathing-compatible symptom pattern. |
Measured once during the single face-to-face evaluation session.
|
|
International Physical Activity Questionnaire Short Form
Periodo de tiempo: Measured once during the single face-to-face evaluation session.
|
This tool will evaluate the participant's physical activity levels over the previous week by recording the duration and frequency of walking and physical activities. |
Measured once during the single face-to-face evaluation session.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 125
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .